Evidence map›Paper›PMID 41581865›Full record

ArticleThe Journal of biological chemistry2026

Activated protein C drives β-arrestin-2- and c-Src-dependent phosphorylation of Cav1 and modulates Cav1 association with PAR1 and GRK5.

Huaping Qin, Lennis B Orduña-Castillo, Olivia Molinar-Inglis, Monica L Gonzalez Ramirez, Miguel A Lopez-Ramirez, Carolyne Bardeleben, JoAnn Trejo

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Huaping QinDepartment of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California, USA.
Lennis B Orduña-CastilloDepartment of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California, USA.
Olivia Molinar-InglisDepartment of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California, USA.
Monica L Gonzalez RamirezDepartment of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California, USA.
Miguel A Lopez-RamirezDepartment of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California, USA; Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, USA.
Carolyne BardelebenDepartment of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California, USA.
JoAnn TrejoDepartment of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California, USA. Electronic address: jotrejo@health.ucsd.edu.

Funding

UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
Training In Cardiovascular Physiology & PharmacologyT32HL007444 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ju Chen, Robert Scott Ross · 1985 to 2026
$11.1M
Endothelial Cytoprotective Signaling by Activated Protein C/Protease-activated Receptor-1R01HL163931 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Joann Trejo · 2023 to 2026
$2.7M
Mechanisms of hypoxia induced exacerbation of cerebral cavernous malformationsR01NS121070 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Miguel Alejandro Lopez-Ramirez · 2022 to 2026
$2.3M
NHLBI NIH HHS R01 HL163931NHLBI NIH HHS T32 HL007444NIGMS NIH HHS K12 GM068524NINDS NIH HHS R01 NS121070
6 · The paper itself

Abstract

G-protein-coupled receptors (GPCRs) display bias toward either G proteins or GPCR kinase (GRK)-mediated β-arrestin (βarr) signaling depending on the agonist-stabilized receptor conformation. The cellular context and subcellular location of GPCRs can also influence biased signaling through mechanisms that are not well understood. The protease-activated receptor-1 (PAR1) exhibits signaling bias in response to thrombin and activated protein C (APC). APC-induced βarr2-biased signaling requires PAR1 compartmentalization in caveolae, a subtype of lipid rafts, whereas thrombin-activated PAR1 G protein signaling does not. Caveolin-1 (Cav1) is the principal structural component of caveolae and regulates protein-protein interactions. The mechanisms by which Cav1 contributes to APC-PAR1-induced βarr2-biased signaling are not known. Here, we report that a substantial population of endogenous PAR1 colocalizes with Cav1 in endothelial cells and is modulated by APC, assessed by single-molecule super-resolution stochastic optical reconstruction microscopy imaging. APC activation of PAR1 also induces Cav1 tyrosine-14 phosphorylation through a βarr2- and c-Src-dependent pathway, which disrupts PAR1-Cav1 coassociation. A smaller population of endogenous GRK5 was also found to colocalize with Cav1 in endothelial cells and was modestly altered by APC activation of PAR1. Moreover, GRK5 was found to interact with Cav1 in intact cells through an N-terminal aromatic-rich Cav1 binding motif. Mutation of this motif disrupts GRK5-Cav1 binding, shifts GRK5 predominantly to the cytoplasm rather than the plasma membrane, and perturbs GRK5-mediated βarr2 recruitment to APC-activated PAR1. Thus, beyond its structural function, Cav1 participates in protein-protein interactions with PAR1 and GRK5, two key effectors that enable APC-induced βarr2 signaling.

Indexed as

beta-Arrestin 2Caveolin 1G-Protein-Coupled Receptor Kinase 5Protein CReceptor, PAR-1src-Family KinasesCSK Tyrosine-Protein KinaseHumansPhosphorylationSignal Transductionbeta-Arrestin 2CAV1 protein, humanCaveolin 1CSK protein, humanCSK Tyrosine-Protein KinaseG-Protein-Coupled Receptor Kinase 5GRK5 protein, humanProtein CReceptor, PAR-1src-Family KinasesAPCarrestinbiased signalingcaveolinc-SrcendothelialGPCRGPCR kinaseGRKprotease-activated receptor-1thrombin

Identifiers

PMID41581865
PMCPMC12925215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.